Anokion SA: Anokion Announces $35 Million Equity Investment from Pfizer

Funding Supports Advancement of KAN-101 for Celiac Disease into Phase 2 Clinical Development Pfizer Representatives Join Scientific Advisory Board and Board of Directors Anokion SA, a clinical-stage

Related Keywords

Switzerland ,Swiss ,Alicia Davis ,Deborah Geraghty ,Allison Kean ,Michael Vincent ,Pfizer ,Strategic Communications ,Worldwide Business Development ,Drug Administration ,Clinical Development ,Pfizer Breakthrough Growth Initiative ,Funding Supports Advancement ,Celiac Disease ,Representatives Join Scientific Advisory Board ,Pfizer Breakthrough Growth ,Inflammation Immunology ,Digestive Disease Week ,Fast Track ,Anokion ,Nnounces ,Billion ,Equity ,Investment ,Rom ,